The UMDNJ-Center for Continuing and Outreach Education is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical Education for physicians.
The UMDNJ-CCO designates this educational activity for a maximum of 1 credit AMA PRA Category 1 credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
12/05/07
MEB 102 |
Treatment Options for Myasthania Gravis: UnMuSKing a New Phenotype
Gil I. Wolfe, MD
Associate Professor of Neurology
UT Southwestern Medical Center
Learning Objective: To recognize current treatment options in MG and to become familiar with clinical features and treatment responses in MuSK-Ab-positive MG. |
12/12/07
MEB 102 |
Pediatric Multiple Sclerosis and
Demyelinating Disorders: Diagnosis, Treatment and Future Directions
Tanuja Chitnis MD
Assistant Professor in Neurology
Harvard Medical School
Learning Objective: To become familiar with the newly introduced classification system and treatment regimens for pediatric demyelinating diseases including multiple sclerosis and ADEM.. |
12/19/07
CAB 1302 |
Superior Semicircular Canal Dehiscence and
the Evaluation of the Dizzy Patient
Martin Gizzi, MD, PhD
Professor and Chairman
NJ Neuroscience Institute
Learning Objective: To describe the anatomy of superior semicircular canal dehiscence and name three typical presenting symptoms. |
01/09/08
MEB 102 |
Update on the Restless Legs Syndrome and Periodic Limb Movements in Sleep
Arthur S. Walters, MD
Director, Center for Sleep Disorders
Treatment, Research & Education
New Jersey Neuroscience Institute at
JFK Medical Center
Professor Dept of Neuroscience
Seton Hall University School of
Graduate Medical Education
Learning Objective: To understand the
pathogenesis and treatment of Restless Legs Syndrome and Periodic Limb Movements in Sleep. |
01/16/08
CAB 1302 |
Recent Advances in Migraines
Brian L. Gerhardstein, MD, PhD
Assistant Professor
Department of Neurology
UMDNJ/RWJMS
Learning Objective: The learners will update
their knowledge on theories of the cause of migraine and newer techniques for preventive
and abortive treatment of attacks. |
01/23/08
CAB 1302 |
Immunology, Neurodegeneration and
Repair in the Central Nervous System in
Multiple Sclerosis and Other Diseases
Robert P Lisak, MD
Parker Webber Chair of Neurology
Professor and Chair of Neurology
Professor of Immunology and Microbiology
Wayne State University School of Medicine
Learning Objective: To understand our
current concepts of the role of the immune
system in mediating damage and repair in
Multiple Sclerosis and other diseases of the CNS. |
01/30/08
CAB 1302 |
Diagnosis, Complications, and Treatment of
Aneurysmal Subarachnoid Hemorrhage
Michael Moussouttas, MD
Assistant Professor of Neurology
Division of Vascular & Critical Care Neurology
Thomas Jefferson University Hospital
Learning Objective: To become familiar
with the multifaceted disease aspects of SAH.
|
02/06/08
CAB 1302 |
Diagnosis and Management of Cervical
Myelopathy
Gino Chiappetta, MD
Assistant Professor
Department of Orthopaedic Surgery
UMDNJ/RWJMS
Learning Objective: To discuss the current
diagnostic and treatment modalities of
cervical myelopathy. |
02/13/08
MEB 102 |
Neuro-Revascularization Techniques, Stroke
Treatments of the Future
Jeffrey Farkas MD
Associate Professor
New York College of Osteopathic Medicine
Learning Objective: To learn about new interventional techniques for the prevention and treatment of the acute stroke patient. |
02/20/08
CAB 1302 |
The Benefits and Toxicity of Cerebral
Hyperoxia in Acute Brain Injury
Gary Fiskum, PhD
Professor and Vice-Chair
Dept. of Anesthesiology
University of Maryland School of Medicine
Learning Objective: To develop an understanding of why cerebral hyperoxia can be either beneficial or toxic, depending on the form of acute brain injury. |
02/27/08
CAB 1302 |
Special Issues of Elderly with Epilepsy
Brenda Wu, MD, PhD
Assistant Professor
Department of Neurology
UMDNJ/RWJMS
Learning Objective: To recognize epileptic
symptoms and to learn strategies in
management of 'new-onset' seizures in
elderly. |
03/05/08
CAB 1302 |
2nd Annual Roger C. Duvoisin Visiting
Lecture in Movement Disorders
History of Movement Disorders: Parkinson's
Disease, Huntington's Disease, and Dystonia
Christopher G. Goetz, MD
Professor of Neurological Sciences
Professor of Pharmacology
Rush University Medical Center
Learning Objective: To understand the
historical foundations of movement disorders
and their impact on contemporary concepts of
pathophysiology and treatment. |
03/12/08
MEB 102 |
Mouse Models for Translation Research in
Parkinson’s Disease
Eric K. Richfield, MD, PhD
Associate Professor
Pathology Lab Medicine
UMDNJ/RWJMS
Learning Objective: Learn how to interpret
mouse models for use in translational
research. |
03/19/08
CAB 1302 |
Eye Muscle Susceptibility To Myasthenia Gravis
Henry J. Kaminski, MD
Professor & Chairman
Department of Neurology & Psychiatry
Saint Louis University
Learning Objective: The audience will
appreciate the unique cellular and molecular
biology of extraocular muscle, which
contributes to their susceptibility to the autoimmune, neuromuscular transmission disorder, myasthenia gravis. |
03/26/08
CAB 1302 |
Engineering New Devices for Epilepsy
Brian Litt, MD
Associate Professor of Neurology and
Bioengineering
University of Pennsylvania
Learning Objective: To learn about new
technologies for mapping and modulating
epileptic networks in humans. |
04/02/08
CAB 1302 |
Disease Modifying Strategies for Parkinson's
Disease
Amy Colcher, MD
Clinical Associate Professor of Neurology
Pennsylvania Neurological Institute
Learning Objective: To enhance understanding of early treatment strategies for Parkinson's disease. |
04/09/08
MEB 102
|
Update on the “Atypical Parkinsonisms”
Lawrence I. Golbe, MD
Professor
Department of Neurology
UMDNJ/RWJMS
Learning Objective: To learn the latest in the
etiology, pathogenesis and treatment of PSP,
MSA and CBD. |
04/23/08
CAB 1302
|
Rationale for Continuous Dopaminergic
Simulation in Parkinson’s disease
M. Maral Mouradian, MD
William Dow Lovett Professor of Neurology
Department of Neurology
UMDNJ/RWJMS
Learning Objective: Present the
pharmacokinetic and pharmacodynamic underpinnings of motor fluctuations in advanced Parkinson’s disease and discuss various modalities for providing continuous dopaminergic therapy. |
04/30/08
CAB 1302
|
What Triggers MS Exacerbation?
Konstantin Balashov, MD, PhD
Assistant Professor
Department of Neurology
UMDNJ/RWJMS
Learning Objective: To review major factors
that can trigger and prevent MS exacerbation. |
05/07/08
CAB 1302 |
Contemplating Alzheimer's as Cancer: Loss
of Neuronal Cell Cycle Control as a Factor in Neurodegenerative Disease
Karl Herrup, PhD
Professor and Chair
Cell Biology and Neuroscience
Rutgers University
Learning Objective: Will have a new
appreciation for the importance of cell cycle regulation, even in a non-dividing cell such as a neuron and understand how loss of cell cycle control places a neuron at risk for death and an individual at risk for neuro-degenerative disease. Examples from both Alzheimer's disease and Ataxia-telangiectasia will be cited. |
05/14/08
MEB 102 |
Complex Partial Seizures: Characteristics,
Dynamics and Options for Therapy
Gregory K. Bergey, MD
Professor of Neurology
Director, Johns Hopkins Epilepsy Center
Co-Director, Epilepsy Research Laboratory
Vice-Chair for Neurological Laboratories
Learning Objective: attendees will have an
enhanced appreciation of the episodic nature
of complex partial seizures and the
implications for treatment. |
5/21/08
CAB 1302 |
Papilledema and its Mimics
Frederick E. Lepore, MD
Professor, Department of Neurology
UMDNJ/RWJMS
Learning Objective: To become familiar with
the fundoscopic features and pathological significance of papilledema and with the varieties of "pseudopapilledema" commonly encountered in neurologic practice. |
